Antimicrobial Susceptibility Testing Market Is Projected to Be Around US$ 4.5 Billion With Healthy CAGR of 6.2% by 2026

Antimicrobial Susceptibility Testing Market – Insights

Increasing number of pathogenic bacteria are acquiring antibiotic resistance and new forms of resistance are continuously emerging, which enable clinicians to perform antimicrobial susceptibility testing (AST) on priority. A rapid multiplexed AST platform provides minimum inhibitory concentrations (MICs) within hours at reasonable cost, which enables rapid determination of effective targeted therapy, resulting in short hospital stays, few laboratory tests, and decreasing morbidity and mortality along with associated healthcare expenses.

The global antimicrobial susceptibility testing market was valued at US$ 2.65 billion in 2017 and is expected to exhibit a CAGR of 6.2% over the forecast period (2018-2026).

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/2449

Global Antimicrobial Susceptibility Testing Market Share (%) Analysis, By Product Type, 2017

Source: Coherent Market Insights Analysis (2019)

Emergence of Multidrug Resistance Worldwide Is Expected To Drive the Antimicrobial Susceptibility Testing Market Revenue

Resistance among various microbial species to different antimicrobial drugs have emerged as a major cause of public health threat. According to World Health Organization (WHO), these resistant microorganisms such as bacteria, fungi, viruses, and parasites are able to combat attack by antimicrobial drugs, which leads to ineffective treatment resulting in persistence and spreading of infections.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2449

Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to increase adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the WHO, in 2016, around 490,000 people worldwide developed MDR-TB. The countries with the largest numbers of MDR/RR-TB cases was China, India, and the Russian Federation.

Moreover, development of genotypic-based methods offering rapid and accurate detection or confirmation of antimicrobial resistance is expected to drive the market growth. For instance, the Accelerate ID/AST System or ID/AST System (Accelerate) aims to reduce the turnaround time by using genetic methods. The device can identify infectious pathogens in a matter of hours instead of days, reducing diagnostic time by 30 to 50 hours.

Antimicrobial Susceptibility Testing Market Restraints

Stringent government regulations is the major restraining factor that is expected to hamper antimicrobial susceptibility testing market growth. Regulatory procedures creates barrier to AST development, as clinical validation and trials are lengthy and often too costly for small-sized or medium-sized enterprises or organizations.

For instance, in the U.S., a manufacturer who intends to market a device of generic type must conform to the general controls of Section 513(a)(1)(B) of the Federal Food, Drug and Cosmetic Act, address the risks to health associated with the AST system, and obtain a substantial equivalence assessment from the FDA.

Antimicrobial Susceptibility Testing Market – Regional Insights

On the basis of region, the global antimicrobial susceptibility testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most lucrative region in the antimicrobial susceptibility testing market in 2017 due to the emergence of a multidrug resistant strain of Salmonella in the U.S. For instance, according to the Centers for Disease Control and Prevention (CDC), September 2018, around two million people are infected with antibiotic-resistant bacteria in the U.S. annually and around 23,000 people die as a result. Moreover, government agencies in the U.S. have taken steps to prevent and control antibiotic resistance, which is expected to increase adoption of antimicrobial susceptibility testing in the country.

Asia Pacific antimicrobial susceptibility testing market revenue is expected to witness significant growth over the forecast period due to high prevalence of microbial infections and increasing consumption of antibiotics, eventually developing resistance among the population. For instance, according to a WHO report, in 2014, multidrug-resistant tuberculosis rates were high in India and treatment for the disease is generally limited.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/antimicrobial-susceptibility-testing-market-to-surpass-us-45-billion-by-2026-1255

Global Antimicrobial Susceptibility Testing Market Value (US$ Mn) & Y-o-Y Growth (%)

Source: Coherent Market Insights Analysis (2019)

Key players operating in the global antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

Detailed Segmentation:

• Global Antimicrobial Susceptibility Testing Market, By Product Type:
  • Manual Antimicrobial Susceptibility Testing Products
    • Susceptibility Testing Disks
    • Mic Strips
    • Susceptibility Plates
  • Automated Laboratory Instruments
  • Consumables
• Global Antimicrobial Susceptibility Testing Market, By Application:
  • Antibacterial
  • Antifungal
  • Anti-parasitic
  • Antiviral
• Global Antimicrobial Susceptibility Testing Market, By Method:
  • Disk Diffusion
  • Rapid Automated AST
  • Broth Dilution
  • Gradient Diffusion
  • Genotypic Methods
• Global Antimicrobial Susceptibility Testing Market, By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.